The expression of AGAP2-AS1, LINC01198, and MIR155HG increased with tumor grade, while TPT-AS1 was considered as a protective lncRNA, with greater expression in the low-risk glioma group [126]. The gene discussed is AGAP2; the disease is central nervous system cancer.